Suppr超能文献

不同剂量口服给药后松黄苷代谢产物在大鼠尿液和胆汁中的排泄及其对醛糖还原酶的抑制活性。

Excretion of tectoridin metabolites in rat urine and bile orally administrated at different dosages and their inhibitory activity against aldose reductase.

作者信息

Qu Jialin, Wu Zhizhen, Gao Jie, Wen Hao, Wang Tao, Yuan Dan

机构信息

Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.

Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 312 Anshanxi Road, Nankai District, Tianjin 300193, China.

出版信息

Fitoterapia. 2014 Dec;99:99-108. doi: 10.1016/j.fitote.2014.09.009. Epub 2014 Sep 22.

Abstract

This study investigated the urinary and biliary excretion of tectoridin, a major active isoflavonoid found in the flowers of Pueraria thomsonii Benth. and the rhizomes of Belamcanda chinensis (L.) DC. Using UHPLC/Q-TOFMS, seven glucuronides and/or sulfated metabolites and four Phase I metabolites were simultaneously quantified in rat urine after oral administration of tectoridin at 100 and 200 mg/kg. Over a 72-h period, 14.2% and 14.7% of the tectoridin were excreted as eleven metabolites in urine, among which, two major metabolites tectorigenin-7-O-β-D-glucuronide (Te-7G) and tectorigenin accounted for 5.5-5.5% and 4.3-4.4%. Furthermore, the cumulative excretion of four glucuronides and sulfated metabolites in bile accounted for 7.3% and 3.9% of the dose within 60 h, among which, Te-7G and tectorigenin-7-O-glucuronide-4'-O-sulfate (Te-7G-4'S) accounted for 2.3-3.0% and 1.4-3.9%, respectively. The results indicate that the urine was the primary elimination route, and glucuronidation after deglycosylation at C-7 position was the major metabolic pathway of tectoridin in vivo. Moreover, the inhibitory activities of tectoridin and its five metabolites on rat lens aldose reductase were confirmed (IC₅₀: 1.4-15.5 μM), whereas irisolidone-7-O-glucuronide (Ir-7G) and irisolidone showed little activity.

摘要

本研究考察了野葛花和射干根茎中主要活性异黄酮鸢尾苷元的尿液和胆汁排泄情况。采用超高效液相色谱/四极杆飞行时间质谱联用仪(UHPLC/Q-TOFMS),在大鼠口服100和200 mg/kg鸢尾苷元后,同时对大鼠尿液中的7种葡萄糖醛酸苷和/或硫酸化代谢产物以及4种I相代谢产物进行了定量分析。在72小时内,鸢尾苷元的14.2%和14.7%以11种代谢产物的形式经尿液排泄,其中两种主要代谢产物鸢尾苷元-7-O-β-D-葡萄糖醛酸苷(Te-7G)和鸢尾苷元分别占5.5 - 5.5%和4.3 - 4.4%。此外,胆汁中4种葡萄糖醛酸苷和硫酸化代谢产物的累积排泄量在60小时内分别占给药剂量的7.3%和3.9%,其中Te-7G和鸢尾苷元-7-O-葡萄糖醛酸苷-4'-O-硫酸盐(Te-7G-4'S)分别占2.3 - 3.0%和1.4 - 3.9%。结果表明,尿液是主要的排泄途径,C-7位去糖基化后的葡萄糖醛酸化是鸢尾苷元在体内的主要代谢途径。此外,还证实了鸢尾苷元及其5种代谢产物对大鼠晶状体醛糖还原酶具有抑制活性(IC₅₀:1.4 - 15.5 μM),而异黄酮-7-O-葡萄糖醛酸苷(Ir-7G)和异黄酮活性较弱。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验